Mass spectrometry (MS) has long been a cornerstone of chemical and biological analysis, but in biotech and biomanufacturing, it is now experiencing a renaissance. As drug modalities diversify—peptides ...

University of Oklahoma researchers have created a new drug delivery system that helps cancer cells take in much more of a ...

Australia has launched the world’s first clinical trial testing personalized mRNA cancer vaccines in children suffering from ...

Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...

Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.

A growing body of research continues to reveal information about the Covid virus and its ability to cause harm long after ...

After moving sharply lower on tariff fears to start the week, stocks rallied as most economic indicators point to an economy ...

NEW YORK – Moderna may be pessimistic about the US infectious disease vaccine market, but that outlook doesn't apply to cancer vaccines, the company clarified Friday. Moderna CEO Stéphane Bancel told ...

Our immune system is a fierce brigade. Roaming immune cells scan for bacteria, viruses, and other invaders. They also communicate with tissues to catch early signs of cancer. After detecting a threat, ...

A Moderna spokesperson said the company is aware of the lawsuit and will defend itself. Spokespeople for Pfizer, BioNTech and Johnson & Johnson did not immediately respond to requests for comment.

Jan 6 (Reuters) - Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court on Tuesday for allegedly misusing its messenger RNA technology ‌in manufacturing ...